Jeff Liter

Company: Luminary Therapeutics

Job title: Chief Executive Officer

Seminars:

Expanding CAR-T Targets Beyond CD-19 to Enhance Treatment Efficacy Across Autoimmune Diseases 11:00 am

Evaluate CD-19’s strengths and limitations as the anchor target for CAR-T treatment of autoimmune diseases Explore novel targets to broaden the spectrum and complexity of treatable autoimmune diseases Evaluate available targeting options to pinpoint optimal targets for varying autoimmune and autoinflammatory diseasesRead more

day: Conference Day One Pink Track P1